Clinical Aspects and Treatment of Parkinson Disease: a Biochemical Perspective
No contributors found.
Release Date: 2024-06-10
Parkinson disease (PD), among one of the most prevalent neurodegenerative illness, affecting around 2-3% of people over the age of 65. PD is characterized by intra-cellular aggregates of α-synuclein (syn) and neuron cell loss in the brain region of substantia nigra (SN), which results in deficiency in dopamine levels. Several other types of cell in [...]
